This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
ORIGINAL RESEARCH PAPER
Watt, M. et al. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart doi:10.1136/heartjnl-2011-300444
Rights and permissions
About this article
Cite this article
TAVI likely to be a cost-effective option for SAVR-ineligible patients with severe aortic stenosis. Nat Rev Cardiol 9, 4 (2012). https://doi.org/10.1038/nrcardio.2011.185
Published:
Issue date:
DOI: https://doi.org/10.1038/nrcardio.2011.185